These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5835260)

  • 1. Specific antibody against selective marked malignant cells.
    Burke JF; Morris PJ; Mark VH
    Surg Forum; 1965; 16():98-100. PubMed ID: 5835260
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced immunologic response to tumors.
    Burke JF
    Cancer Res; 1969 Dec; 29(12):2363-7. PubMed ID: 5369682
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic responsiveness and the induction of experimental neoplasms.
    Law LW
    Cancer Res; 1966 Jun; 26(6):1121-34. PubMed ID: 4287788
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary studies on the topography of H-2d and mammary leukaemia (ML) antigens on DBA/2 mouse leukaemia cells.
    Kusnierczyk P; Pĕknicová J
    Folia Biol (Praha); 1975; 21(6):435. PubMed ID: 1204892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempts at active non-specific immunotherapy using formolized Corynebacterium parvum].
    Amiel JL; Litwin J; Bérardet M
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):909-12. PubMed ID: 5365728
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of cellular and humoral immunity in mice infected with Rauscher leukemia virus following administration of serum against isologous aggregated immunoglobulins].
    Snegireva AE; Khorobrykh VV; Kaulen DR; Merimskaia OS; Shevliagin VIa
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (7):27-33. PubMed ID: 6967739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 9. The histocompatibility-2 locus and susceptibility to tumor induction.
    Lilly F
    Natl Cancer Inst Monogr; 1966 Sep; 22():631-42. PubMed ID: 4288570
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Fourth Perugia Quadrennial International Conference on Cancer" in Perugia, Italy from June 26 to July 1, 1969].
    Pasternak G
    Arch Geschwulstforsch; 1970; 35(2):146-9. PubMed ID: 5522598
    [No Abstract]   [Full Text] [Related]  

  • 11. Thermally-enhanced tumor regression in mice treated with melphalan.
    Goldfeder A; Neubort S
    Anticancer Res; 1984; 4(1-2):17-22. PubMed ID: 6712172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of natural antibody to the G (gross) leukemia antigen in mice.
    Aoki T; Boyse EA; Old LJ
    Cancer Res; 1966 Jul; 26(7):1415-9. PubMed ID: 5911583
    [No Abstract]   [Full Text] [Related]  

  • 13. Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus.
    Akaogi J; Nacionales DC; Kuroda Y; Reeves WH; Satoh M
    Arthritis Rheum; 2003 Oct; 48(10):2990-2. PubMed ID: 14558108
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of combined glycolytic inhibitor, respiratory inhibitor, and protein antagonist on experimental tumor growth.
    Silverstein MN; Linman JW
    Mayo Clin Proc; 1967 Jun; 42(6):313-7. PubMed ID: 6025632
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody.
    Stackpole CW
    J Natl Cancer Inst; 1980 Apr; 64(4):917-23. PubMed ID: 6929003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the immunogenicity of tumor cells and the pattern of metastasis.
    Kim U
    Symp Fundam Cancer Res; 1983; 36():337-52. PubMed ID: 6382512
    [No Abstract]   [Full Text] [Related]  

  • 19. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the immune status as a function of age and the appearance of spontaneous mammary tumors in C3H/Bi mice].
    Dufer J; Benoist H; Bouchet C; Desplaces A; Saracino RT
    Bull Cancer; 1982; 69(2):143-8. PubMed ID: 7126886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.